Assisted spontaneous remission from alcohol problems: Effects of a controlled drinking self-help manual with and without added telephone contact
NDARC Technical Report No. 6 (1990)
SUMMARY
NDARC Technical Report No. 6 (1990)
SUMMARY
Australian surveys of those with cannabis use disorder (CUD) reveal that general medical practitioners (GPs) are the preferred source of treatment as they are seen as trust worthy and confidential.
This randomised double-blind placebo-controlled study, led by St Vincent's Hospital Sydney, aims to examine the safety and efficacy of lisdexamfetamine in the treatment of adults with severe methamphetamine (MA) dependence.
Tobacco smoking is a leading cause of preventable disease and death. Smoking rates are higher among disadvantaged Australians and facilitating smoking cessation in this group is a national health priority.
This study aimed to examine the feasibility of agonist maintenance treatment for the major psychoactive drug classes: opioids, nicotine, benzodiazepines, cannabis, psychostimulants and alcohol.
• almost half of long-term heroin users have previously attempted suicide, compared with 3% of the general population
• one in 10 considers suicide
• one in 20 has a suicide plan
The National Drug and Alcohol Research Centre (NDARC) have been invited to work with 5 remote NSW communities to retrospectively evaluate a suite of interventions aimed at prevention of drug and alcohol harms from 2012-2014.
A treatment program developed by NDARC researchers & colleagues to tackle co-occurring post-traumatic stress disorder (PTSD) and substance use disorders will soon be available to clinicians and patients worldwide thanks to a publishing deal with Oxford University Press.
This project explores the characteristics of methamphetamine users entering treatment in therapeutic communities, and assesses the effectiveness of a specialist amphetamine-type stimulants (ATS) intervention in therapeutic communities.